Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY10 | O00398 | 11/20 | 0.76 |
| ▸ | GPR174 | Q9BXC1 | 9/20 | 0.76 |
| ▸ | GPR34 | Q9UPC5 | 6/20 | 0.76 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.73 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.73 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.73 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.73 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.73 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.73 |
| ▸ | CES2 | O00748 | 1/20 | 0.73 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.73 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25354353 | 1.00 | P2RY10 (0.76) | P2RY10GPR174GPR34LPAR1ENPP2 | |
| SCHEMBL22493901 | 1.00 | P2RY10 (0.76) | P2RY10GPR174GPR34LPAR1ENPP2 | |
| SCHEMBL31442523 | 1.00 | P2RY10 (0.76) | P2RY10GPR174GPR34LPAR1ENPP2 | |
| SCHEMBL14924218 | 1.00 | P2RY10 (0.76) | P2RY10GPR174GPR34LPAR1ENPP2 | |
| SCHEMBL31442307 | 1.00 | P2RY10 (0.76) | P2RY10GPR174GPR34LPAR1ENPP2 | |
| SCHEMBL30913715 | 0.98 | LPAR1 (0.73) | P2RY10GPR174GPR34LPAR1ENPP2 | |
| SCHEMBL32666125 | 0.97 | P2RY10 (0.71) | P2RY10GPR174GPR34LPAR1ENPP2 | |
| SCHEMBL275621 | 0.97 | P2RY10 (0.71) | P2RY10GPR174GPR34LPAR1ENPP2 | |
| SCHEMBL17929051 | 0.97 | P2RY10 (0.71) | P2RY10GPR174GPR34LPAR1ENPP2 | |
| SCHEMBL275624 | 0.94 | LPAR1 (0.67) | P2RY10GPR174GPR34LPAR1ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026089660-A1 | A PLATFORM FOR MIMICKING BIOLOGICAL AIR-INTERFACES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2026-04-30 | — | — | WO | claimed |
| EP-4731002-A2 | SYSTEMS FOR PRODUCTION OF PRODUCTS TO PROMOTE NITROGEN USE EFFICIENCY IN PLANTS | Tenfold Technologies, LLC (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4627352-A1 | DIAGNOSIS OF METABOLIC CHANGES OF THE LIVER BY WAY OF METABOLIC ANALYSIS OF ERYTHROCYTES BY MASS SPECTROMETRY | Universitätsklinikum Jena (DE) | 2025-10-08 | — | — | EP | claimed |
| EP-4537111-A2 | MULTI-OMICS ASSESSMENT | Prognomiq Inc (US) | 2025-04-16 | — | — | EP | claimed |
| CN-119816897-A | Multiple study assessment | 普罗科技有限公司 | 2025-04-11 | — | — | CN | claimed |
| US-20250027938-A1 | METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2025-01-23 | — | — | US | claimed |
| WO-2024263793-A2 | SYSTEMS FOR PRODUCTION OF PRODUCTS TO PROMOTE NITROGEN USE EFFICIENCY IN PLANTS | Tenfold Technologies, LLC (US) | 2024-12-26 | — | — | WO | claimed |
| CN-118777442-A | Lung cancer lipid marker, application thereof and lung cancer specific diagnostic kit | 复旦大学附属中山医院 | 2024-10-15 | — | — | CN | claimed |
| WO-2024168236-A2 | METHODS FOR DETECTING AND TREATING CAVERNOUS ANGIOMA | THE UNIVERSITY OF CHICAGO (US) | 2024-08-15 | — | — | WO | claimed |
| CN-118425358-A | Use of lipid markers in detection of polycystic ovary syndrome | 北京大学第三医院（北京大学第三临床医学院） | 2024-08-02 | — | — | CN | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-111273044-B | Method for evaluating temperature and humidity state of environment where individual growth of nursery pigs is located | 中国科学院亚热带农业生态研究所 | 2023-08-18 | — | — | CN | claimed |
| WO-2023285832-A1 | METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-01-19 | — | — | WO | claimed |
| US-20220354963-A1 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | CODIAK BIOSCIENCES, INC. (US) | 2022-11-10 | — | — | US | claimed |
| EP-4056552-A1 | USE OF LIPID IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT THEREOF | Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CN) | 2022-09-14 | — | — | EP | claimed |
| CN-114728078-A | Extracellular vesicles linked to molecules and uses thereof | 科迪亚克生物科学公司 | 2022-07-08 | — | — | CN | claimed |
| CN-114650982-A | Application of lipid in preparation of nucleic acid delivery agent and related product thereof | 中国医学科学院基础医学研究所 | 2022-06-21 | — | — | CN | claimed |
| US-20220152559-A1 | STABILIZED FILTRATION DEVICE | RETEIN AB (SE) | 2022-05-19 | — | — | US | claimed |
| EP-3987290-A1 | SERIES OF METABOLITES AS BIOMARKERS FOR THE DIAGNOSIS OF PANCREATIC CANCER | Universidad de Granada (ES) | 2022-04-27 | — | — | EP | claimed |
| CN-111505099-A | Diagnostic marker for NASH and application thereof | 上海市普陀区中心医院 | 2020-08-07 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220354963-A1 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | EXOSC5, EXOSC4, EXOSC10 | P2RY10 4135/4885GPR174 4690/4885GPR34 4442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.